CBD Industry Toxicology Data Review
Three Points to Discuss Part 3 - The Curious Case of RP427
Three Points to Discuss Part 2 - Ethics and the FSA
Three Points to Discuss Part 1 - The FSA and the ASA
Escalation - a preview of The Hemp Hound Agency's meeting with the FSA to discuss the Public Interest Disclosure Complaint against their handling of novel foods for CBD products
The Hemp Hound Agency's review of Cannabis in the UK
Public Interest Disclosure complaint Update (21/07/23)
The Deloitte report: A Controversial Collaboration Shrouded in Industry Influence
Killing in the Name of .... - A look at the MHRA's yellow card list for Cannabis Sativa
The true extent of control
Hemp & CBD Industry Poll: 20/02/2023
Deloitte - A look at those about to redefine Novel Food Regulations
February's Directory Push: US/UK edition
Communication issues
Ask the MHRA
Battleplans for 2023
The Hemp Hound Reset!
Have EIHA dropped the ball?
'Ask The FSA' FAQ's: Cold Press Hemp Oil with an Advertised Cannabinoid Content, and Article 4's
Public Interest Disclosure update